Park Square has placed David McMullin as Senior Vice President, Corporate Development and Strategy at Aldeyra Therapeutics.
{
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, announced the hiring of David McMullin to the newly created position of Senior Vice President, Corporate Development and Strategy. Mr. McMullin will be responsible for leading Aldeyra's commercial planning, corporate development, and business development efforts.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
